Pages that link to "Q52875546"
Jump to navigation
Jump to search
The following pages link to Dominik Linz (Q52875546):
Displaying 50 items.
- Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? (Q27009311) (← links)
- Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model (Q28550653) (← links)
- Functional value of elytra under various stresses in the red flour beetle, Tribolium castaneum (Q28597898) (← links)
- Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies (Q30251913) (← links)
- Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. (Q30772422) (← links)
- Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies (Q34640125) (← links)
- Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats (Q36430309) (← links)
- The nervous heart (Q36730662) (← links)
- Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats. (Q36982120) (← links)
- Treating resistant hypertension: role of renal denervation. (Q37218107) (← links)
- Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias. (Q38111569) (← links)
- Expanding the indication spectrum: renal denervation in diabetes. (Q38111570) (← links)
- Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure. (Q38111571) (← links)
- The sympathetic nervous system in chronic kidney disease. (Q38112066) (← links)
- Renal sympathetic denervation: applications in hypertension and beyond. (Q38115114) (← links)
- Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research (Q38181036) (← links)
- Renal denervation: a novel non-pharmacological approach in heart failure (Q38191875) (← links)
- Novel and nonpharmacologic approaches to cardio-protection in hypertension. (Q38196355) (← links)
- Renal denervation and heart failure. (Q38197134) (← links)
- Renal denervation: effects on atrial electrophysiology and arrhythmias (Q38200501) (← links)
- Obstructive sleep apnea and atrial arrhythmogenesis (Q38227380) (← links)
- Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? (Q38230820) (← links)
- Role of endo-epicardial dissociation of electrical activity and transmural conduction in the development of persistent atrial fibrillation. (Q38236256) (← links)
- Effects of renal denervation on atrial arrhythmogenesis (Q38286295) (← links)
- Inhibition of NHE3-mediated Sodium Absorption in the Gut Reduced Cardiac End-organ Damage Without Deteriorating Renal Function in Obese Spontaneously Hypertensive Rats (Q38294497) (← links)
- Drug therapy for the patient with resistant hypertension (Q38373858) (← links)
- Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model. (Q38412937) (← links)
- The importance of sleep-disordered breathing in cardiovascular disease. (Q38436072) (← links)
- Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications (Q38549526) (← links)
- Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis (Q38671375) (← links)
- Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction. (Q38849684) (← links)
- Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation. (Q38951792) (← links)
- Experimental Evidence Of The Role Of Renal Sympathetic Denervation For Treating Atrial Fibrillation (Q39037043) (← links)
- Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation. (Q39421654) (← links)
- Progression and reversibility of stretch induced atrial remodeling: Characterization and clinical implications. (Q39452172) (← links)
- Proteomic Profiling of Cardiomyocyte-Specific Cathepsin A Overexpression Links Cathepsin A to the Oxidative Stress Response. (Q39587092) (← links)
- 8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY. (Q40808260) (← links)
- Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner. (Q40908969) (← links)
- Sleep-disordered breathing and cardiac disease (Q41453645) (← links)
- Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats (Q42373750) (← links)
- Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction (Q44169580) (← links)
- Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension (Q44557638) (← links)
- Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. (Q44898822) (← links)
- Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. (Q45058890) (← links)
- Orthostatic function after renal sympathetic denervation in patients with resistant hypertension (Q46231863) (← links)
- Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry (Q46306396) (← links)
- Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries. (Q46558328) (← links)
- Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies. (Q46634814) (← links)
- Treatment of obstructive sleep apnoea improves metabolic conditions and prevents initiation of antiarrhythmic therapy in a patient with atrial fibrillation. (Q46928439) (← links)
- Effect of atrial electrical remodeling on the efficacy of antiarrhythmic drugs: comparison of amiodarone with I(Kr)- and I(to)/IKur-blockade in vivo. (Q46966624) (← links)